|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Enterovirus Panel, CF, CSF
Test Code12672
CPT Codes
86658 (x11)
Includes
Coxsackie A Antibodies, CSF
Echovirus Antibodies, CSF
Echovirus Antibodies, CSF
Preferred Specimen
5 mL CSF collected in a sterile leak-proof container
Minimum Volume
2 mL
Transport Container
Sterile leak-proof container
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly icteric
Methodology
Complement Fixation (CF)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up and Report available: See individual assays
Reference Range
Coxsackie A Antibodies, CSF
Echovirus Antibodies, CSF
| Coxsackie A2 Ab | <1:1 titer |
| Coxsackie A4 Ab | <1:1 titer |
| Coxsackie A7 Ab | <1:1 titer |
| Coxsackie A9 Ab | <1:1 titer |
| Coxsackie A10 Ab | <1:1 titer |
| Coxsackie A16 Ab | <1:1 titer |
Echovirus Antibodies, CSF
| Echovirus 4 Ab | <1:1 titer |
| Echovirus 7 Ab | <1:1 titer |
| Echovirus 9 Ab | <1:1 titer |
| Echovirus 11 Ab | <1:1 titer |
| Echovirus 30 Ab | <1:1 titer |
Clinical Significance
Detectable antibodies to enteroviruses in CSF may indicate central nervous system infection. Patients with detectable titers should be further evaluated using molecular methods to directly identify enteroviruses in the CSF.
